Home › Long COVID › Georgia
Long COVID clinical trials in Georgia
10 studies for Long COVID are looking for participants at sites in Georgia.
Cities in Georgia
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Renew Health Clinical Research ( Site 3760), Snellville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06667700Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Augusta University, Augusta
RecruitingPhase 3
28 Days · All sexes · Updated Nov 4, 2026 · NCT02735707A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- The Hope Clinic of Emory University, Decatur
- Javara - Privia Medical Group Georgia - Fayetteville, Fayetteville
- Coastal Heritage Clinical Research, Hinesville
- and 1 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Oct 15, 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Velocity Clinical Research, Savannah, Savannah
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07013474A Study of COVID-19 Vaccine(s) in Children and Adults
- AGILE Clinical Research Trials, LLC, Atlanta
RecruitingPhase 3Healthy volunteers welcome
Ages 5 and older · All sexes · Updated Sep 28, 2026 · NCT07798648Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- Emory University, Atlanta
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06631287A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- GSK Investigational Site, Stockbridge
RecruitingPhase 1
Ages 65 to 85 · All sexes · Updated Jun 30, 2026 · NCT07464314Arginine Replacement Therapy in COVID-19
- Children's Healthcare of Atlanta (CHOA), Arthur M. Blank, Atlanta
RecruitingPhase 2
Ages 3 to 21 · All sexes · Updated Apr 15, 2026 · NCT05855330A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- CenExel, Atlanta
- CenExel, Decatur
RecruitingPhase 4Healthy volunteers welcome
6 Months · All sexes · Updated Mar 27, 2026 · NCT06585241EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
RecruitingPhase 3
Ages 0 to 17 · All sexes · Updated Jul 17, 2025 · NCT05261139From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.